Background: Our aim in this study is to investigate the effect of protocatechuic acid (PCA) on lipid profile and DNA damage in D-galactosamine (D-GalN)-induced hepatotoxic rats.
Introduction
Liver toxicity due to poisons used in experimental model rarely occurs in human beings. It is, therefore, important to use hepatotoxic agents that are more relevant to human beings such as ethyl alcohol and D-galactosamine (D-GalN) [1] . Hepatitis induced by D-GalN has been reported to show many metabolic and morphologic aberrations in the liver tissue of the experimental animals similar to those observed in human viral hepatitis [2] . D-GalN decreases the hepatic content of uracil nucleotide resulting in the inhibition of transcription and, consequently, the translation processes [3] , thereby affecting cell membrane, organelle, and the synthesis of protein and nucleic acid [4] .
The development of acute liver failure due to the administration of GalN is well documented [4] . Javlé et al. reported that GalN-induced liver injury is associated with the development of renal failure [5] . Hepatorenal syndrome (HRS) has been introduced to define the development of renal failure in the absence of clinical, anatomical, or pathological causes of that failure. Classically, HRS is associated with end-stage liver cirrhosis, and it has been observed that renal failure occurs with this liver disease in about 50% of patients. Although oxidative stress has been reported as one of the major causes of GalN-induced liver damages [6] , high level of blood cholesterol is a contributory factor of atherosclerosis and many lipid-associated ailments like obesity, heart attack, stroke, and kidney failure. Previous studies showed that lipid-associated disorders are attributed not only to the total serum cholesterol but also to its distribution among different lipoproteins [7] . Low-density lipoproteins (LDLs) are the major carriers of cholesterol towards tissue having atherogenic potential, while high-density lipoproteins (HDLs) carry cholesterol from peripheral tissues to the liver [8] . HDLs thus give protection against many cardiac problems and obesity [9] . Although genetic factor reclined behind this lipid disorder, in most of the cases, it is allied with diets high in saturated fats or trans fats.
According to a previous report, there is a great deal of interest in the health benefits of phenolic compounds because of their antioxidant potential [10] . Protocatechuic acid (PCA) is one of the major benzoic acid derivatives from edible plants and fruits. The in vitro study showed that the antioxidant potential of PCA is 10-fold higher than that of α-tocopherol [11] . PCA is the main ingredient of several Chinese herbal medicines such as Hibiscus sabdariffa L. [12] , Alpina oxyphylla [13] , Lonicera japonica [14] , and Eucommia ulmoides Oliv [15] . PCA has been demonstrated to show strong antioxidant [11] , anticarcinogenic [16] , and cardioprotection [17] .
The drug silymarin (standard hepatoprotective drug) provides hepatoprotection against poisoning by ethanol, D-galactosamine, thiocetamide, halothane, acetaminophen, and carbon tetrachloride [18] and hence was used as a reference drug in this study.
This study attempted to examine whether PCA could be effective against D-GalN-induced changes in lipid profile and hepatic marker enzymes activities during acute liver damage in experimental rats. 
Materials and methods

Chemicals
Experimental induction of hepatotoxicity
The animals were made hepatotoxic by intraperitoneal injection (I.P.) of D-GalN (400 mg/kg BW) in a freshly prepared physiological saline as a single dose on the first day of the experiment.
Experimental design
The animals were randomly divided into five groups of six rats each. PCA and silymarin were administered orally once a day in the morning for 20 days. Physiological saline (0.9%) was used as a vehicle solution to the control as well as for the administration of PCA and silymarin and fed by intubation.
Group I : Control (physiological saline orally, from 1st day to 21st day) Group II : Control+PCA (100 mg/kg BW, orally from 2nd day to 21st day)
Group III : Control+D-GalN (400 mg/kg BW, I.P., for 1st day only)
Group IV : D-GalN (400 mg/kg BW)+PCA (100 mg/kg BW, orally from 2nd day to 21st day)
Group V : D-GalN (400 mg/kg BW)+Silymarin (25 mg/kg BW, orally from 2nd day to 21st day)
At the end of experimental period (i.e. 22nd day), the rats were sacrificed by cervical dislocation. Blood samples were collected in a dry test tube and allowed to coagulate at ambient temperature for 40 min. Serum was separated by centrifugation at 2000 rpm for 10 min. The blood, collected in a centrifuge tube containing heparin, was centrifuged at 2000 rpm for 10 min, and the plasma was separated by aspiration. The liver and kidney tissues were excised immediately, washed with chilled isotonic saline, and used for the various parameters analysis.
Hepatocyte preparation
Liver was cut into small pieces and washed with Hank's balanced salt solution. The individual cell suspensions were obtained by enzymic digestion with collagenase at 37 °C. After filtration on 100-and 40-mm mesh successively, the resulting cell suspensions were centrifuged for 10 min at 3000 rpm. The cell pellet was then suspended in phosphatebuffered saline and used for the estimation of DNA damage.
Activities of serum marker enzymes
The activities of serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were estimated using the method of Reitman and Frankel [19] . Alkaline phosphatase (ALP), γ-glutamyl transpeptidase (GGT), and bilirubin were estimated using the method of Kind and King [20] and Rosalki and Rau [21] , respectively.
Estimation of kidney function markers
Serum urea, uric acid, and creatinine were estimated by using the diagnostic kit based on the methods of Fawcett and Scott [22] , Caraway [23] , Tietz [24] , and Jaffe [25] , respectively.
Assessment of lipid profile in plasma, liver and kidney
Plasma and tissue lipids were extracted using the methods of Folch et al. [26] . Plasma and tissue total cholesterol, triglycerides, free fatty acids, and phospholipids were estimated using the methods of Allain et al. [27] , McGowan et al. [28] , Falholt et al. [29] , and Zilversmit and Davis [30] , respectively. Plasma high-density lipoprotein-C was estimated using the method of Izzo et al. [31] . Low-density lipoprotein-C and very low-density lipoprotein-C were calculated using Friedwald's formula [32] .
Alkaline single-cell gel electrophoresis (Comet assay)
DNA damage was estimated by alkaline single-cell gel electrophoresis according to the method of Singh et al. [33] . A layer of 1% normal melting agarose was prepared on microscope slides. Hepatic cells (50 μL in 1 × 10 6 cells) were mixed with 100 μL of 1% low melting agarose. The suspension was pipetted onto the precoated slides. Slides were immersed in cold lysis solution at pH 10 and kept at 4 °C for 60 min. After lysis, the slides were placed in alkaline electrophoresis buffer at pH 13 and left for 25 min. Subsequently, slides were transferred to an electrophoresis tank with fresh alkaline electrophoresis buffer, and electrophoresis was performed at field strength of 25 V and 300 mA for 25 min at 4 °C. Slides were neutralized in 0.4 M Tris, pH 7.5, for 5 min and stained with 20 μg/mL ethidium bromide. For visualization of DNA damage, observations were made using a 40 × objective on an epifluorescent microscope equipped with an excitation filter of 510-560 nm and a barrier filter of 590 nm. Images were captured with a digital camera with networking capability and analyzed by image analysis software, CASP.
Histopathology
Liver and kidney tissue was fixed in 10% formalin, routinely processed, and embedded in paraffin. Paraffin sections (3 μm) were cut, fixed on glass slides, and stained with hemotoxylin and eosin (H&E) and examined under a light microscope.
Statistical analysis
Statistical analysis was performed by one-way analysis of variance (ANOVA), and the groups were compared by Duncan's Multiple Range Test (DMRT) using SPSS Software Package, version 10.0. Results were expressed as means ± standard deviation for six rats in each group. A value of p ≤ 0.05 was considered to be statistically significant.
Results
Activities of serum marker enzyme Table 1 shows the effects of PCA on the activities of serum hepatic marker enzymes such as AST, ALT, ALP, and GGT in D-GalN hepatotoxic and control rats. Increased activities of AST, ALT, ALP, and GGT were observed in D-GalNinduced rats. Oral administration of PCA and silymarin improved these parameters towards normalcy. Table 2 shows the effect of PCA on serum kidney function markers in D-GalN hepatotoxic and control rats. The levels of urea, uric acid, and creatinine significantly increased in D-GalN-induced rats, and treatment with PCA and silymarin significantly decreased the levels of urea, uric acid, and creatinine. Table 3 shows the effects of PCA on the levels of TC, TG, PL, and FFA in the plasma of control and D-GalN-induced rats. A significant elevation of plasma TC, TG, PL, and FFA was observed in D-GalN-induced rats. The administration of PCA and silymarin decreased the levels of TC, TG, PL, and FFA. Values not sharing a common superscript (a,b,c) differ significantly at p < 0.05 (DMRT). Table 4 represents the effects of PCA on the levels of HDL-C, LDL-C, and VLDL-C in the plasma of control and D-GalN-induced rats. A significant elevation of plasma LDL-C and VLDL-C and reduction in HDL-C were observed in D-GalN-induced rats. The administration of PCA and silymarin decreased in the levels of low-density lipoprotein-C and very low-density lipoprotein-C and increased the level of high-density lipoprotein-C.
Estimation of kidney function markers
Estimations of lipid profile in plasma
Estimations of lipoproteins in plasma
Estimations of lipid profile in liver and kidney
The tissue (liver, kidney) concentration of TC, TG, PL, and FFA of experimental rats is shown in Tables 5 and 6 . In D-GalN-induced rats, the levels of these lipid parameters increased. Treatment with PCA and silymarin decreased the levels of lipid parameters towards normal level. Figure 1 (A and B) shows the changes in the levels of DNA damage (percentage of head and tail DNA and tail length) in the hepatocyte of control and D-GalN-induced rats. D-GalN-induced rats significantly increased the percentage of tail DNA and tail length and decreased the percentage of head DNA. PCA administration significantly decreased the levels of DNA damage. Values not sharing a common superscript (a,b,c,d) differ significantly at p < 0.05 (DMRT). Values not sharing a common superscript (a,b,c) differ significantly at p < 0.05 (DMRT). Values not sharing a common superscript (a,b,c,d) differ significantly at p < 0.05 (DMRT).
Evaluating DNA damage by Comet assay
Histopathological observations
rats. In D-GalN-induced rats, the liver showed micro and macro vesicular fatty changes and the kidney showed cloudy swelling of tubules. PCA administration in D-GalNinduced rats brought back to near normal level the liver and kidney.
Discussion
The present study has demonstrated the hepatoprotective and antihyperlipidemic effect of PCA on D-GalN-induced hepatotoxicity in rats. D-GalN, a well-known hepatotoxin that produces non-zonal lesions, has been used as a model of massive hepatic inflammation limited to hepatocytes [34] . D-GalN administration in rats disrupts the membrane permeability of the plasma membrane causing leakage of the enzymes from the cell, which leads to elevation in levels of serum enzymes. Elevated serum enzymes are indicative of the cellular leakage and loss of functional integrity of the cell membrane in the liver [35] . Hence, significant rise in the transaminases levels could be taken as liver damage. The serum marker enzymes (AST, ALT) are cytoplasmic in nature, but upon liver injury, these enzymes enter into the circulatory system due to the altered permeability of membrane [36] . Hepatoprotective activity upon PCA treatment might be due to its effect against cellular leakage and loss of functional integrity of the cell membrane in hepatocytes.
ALP is a membrane-bound glycoprotein enzyme and has been shown to be present in high concentration in the sinusoids and the endothelium of the central and periportal veins [37] . It has been reported to be involved in the transport of metabolites across the cell membranes, protein synthesis, secretory activities, and glycogen metabolism. Thus, the rise in serum ALP activity in D-GalN-induced rats may be due to a disturbance in the secretary activity or in the transport of metabolites or may be due to altered synthesis of certain enzymes as in the other hepatotoxic conditions [38] . In D-GalN-induced rats treated with PCA, the enzyme activities were improved, indicating clearly the therapeutic value of PCA in hepatotoxicity.
GGT is embedded in the hepatocyte plasma membrane; GGT is the most sensitive indicator of liver disease and is a useful marker in patients with liver metastasis. A number of drugs and chemicals are known to increase GGT activity by the induction of microsomal enzyme [39] . In the present observation, the activity of GGT showed significant increase due to D-GalN induction. This may be due to the fact that the depletion of GSH may induce hepatic GGT activity through an increased synthesis of its mRNA [40] . Treatment with PCA in liver damaged rats showed reduction in GGT activity, thus revealing the membrane stabilizing activity of PCA. Values not sharing a common superscript (a,b,c,d) differ significantly at p < 0.05 (DMRT). Values not sharing a common superscript (a, b, c) differ significantly at p < 0.05 (DMRT).
Urea is the major nitrogen containing metabolic product of protein metabolism; uric acid is the major product of purine nucleotides; creatinine is endogenously produced and released into body fluids and its clearance is measured as an indicator of glomerular filtration rate [41] . The results from the present study showed that D-GalNinduced rats significantly increased the levels of urea, uric acid, and creatinine in serum, as shown in earlier findings [42] , which are considered as significant markers of renal dysfunction. The levels of these renal function markers were much lower in case of D-GalN hepatotoxic rats treated with PCA. It shows that PCA, to an extent, preserves the functional capacity of the kidney from the adverse effects of D-GalN.
The liver is the major site of cholesterol, bile acids, phospholipids synthesis, and metabolism. Marked alterations in lipid metabolism have been reported in D-GalNinduced hepatitis in rats [43] . Our results also showed increased levels of plasma, tissue cholesterol, triglycerides, free fatty acids, and phospholipids in D-GalNinjected rats. The increased cholesterol level may be due to increased HMG-CoA reductase activity, which is the rate-limiting step in cholesterol biosynthesis. PCA treatment enhances the levels of cholesterol in plasma, liver, and kidney. Normally circulating LDL-C undergoes reuptake in the liver via specific receptors and gets cleared from the circulation [44] . This increased LDL concentration in the plasma of D-GalN-induced rats might be due to defect in LDL-C receptor through failure in either its production or its function. HDL-C is protective by reversing cholesterol transport, inhibiting the oxidation of LDL-C, and neutralizing the atherogenic effects of oxidized lowdensity lipoprotein-C. A greater increase of LDL-C and VLDL-C may also cause a greater decrease of HDL-C, as there is a reciprocal relationship between the concentration of VLDL-C and HDL-C. Decreased HDL-C may also be due to diminished lecithin cholesterol acyl transferase activity. In our study, the levels of LDL-C and VLDL-C were found to be increased and HDL-C decreased in D-GalNinduced hepatotoxic rats. Administration of PCA resulted in significantly lowered VLDL-C, LDL-C, and increased HDL cholesterol. Thus, our finding demonstrates that PCA has an antihyperlipidemic effect.
A number of agents that produce liver injury also cause the accumulation of abnormal amounts of fat, predominately triglycerides, in the parenchymal cells. Cartwright et al. [45] have reported the increased accumulation of triglycerides during D-GalN-induced hepatitis in rats, and we observed significantly reduced levels of triglycerides in the plasma and tissues of PCA-treated rats, thus showing the beneficial effect of PCA.
Fatty acids are principal components present in most lipids of biological importance. The increased levels of free fatty acids in D-GalN-injected rats might be due to the indirect effect of elevated calcium levels, which have been reported following D-GalN administration [46] . In free radical mediated tissue injury, lipid peroxidation leads to increase in the level of phospholipids and alteration in membrane fluidity, which is essential for liver cell function. Phospholipids are vital components of biomembranes, and their composition greatly affects the properties and functions of the membrane, including signal transduction [47] . This alteration in the membrane composition might be one of the reasons for the toxic effect caused by D-GalN and PCA administration decreased the levels of free fatty acid and phospholipids, thereby preventing the toxic complication produced by increased levels of these lipids.
In this study, we observed an increase in DNA damage in the hepatocytes of D-GalN-induced hepatotoxic rats, which is in agreement with the previous reports [48] , and PCA administration showed decreased DNA damage. DNA damage in the liver extract has been observed to be related to apoptosis, and administration of D-Gal has been noted to induce intracellular uracil nucleotides in hepatocytes, leading to inhibition of RNA and protein synthesis [49] . DNA damage can occur directly from free radicals or from free radical derived lipid peroxide breakdown to endogenous toxins [50] . The protective effect of PCA may be explained by the scavenging of free radicals before they cause DNA damage, because PCA is a potent antioxidant with the capacity for radical scavenging [11] . Thus, the antioxidant effect of PCA might be responsible for its protective effect against D-GalN-induced DNA damage.
Histopathological examination of D-GalN hepatotoxic liver showed the micro and macro vesicular fatty changes. Administration of PCA showed normal hepatocytes with congested central vein and sinusoidal dilatation, whereas silymarin treatment showed that the central vein surrounded by normal hepatocytes. It shows that PCA has the potency to decrease the severity of D-GalN-induced toxicity as seen in the silymarin-treated group.
Conclusions
In conclusion, PCA administration prevented D-GalNinduced hepatotoxicity via a mechanism that involves a hepatoprotective, antihyperlipidemic activity and protects from DNA damage. These biochemical changes were also supported by histopathological observations. This study provides evidence that PCA might be an alternative treatment for prevention of hepatotoxicity.
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